Key result
Transplantation of uPAR-deficient cardiac mesenchymal progenitor cells after myocardial infarction resulted in reduced cell retention and impaired angiogenesis compared to wild-type cells.
Why the study?
Identifying selective reparative targets to enhance stem or progenitor cell therapeutic efficacy remains a major challenge in implementing cardiac cell therapy.
Answers are grounded in this paper and cite their sources.
uPAR is essential for the survival, engraftment, and proangiogenic effects of cardiac mesenchymal progenitor cells, highlighting it as a potential target to optimize cell-based therapies for ischemic heart disease.
One of the largest challenges to the implementation of cardiac cell therapy is identifying selective reparative targets to enhance stem/progenitor cell therapeutic efficacy. In this work, we hypothesized that such a target could be an urokinase-type plasminogen activator receptor (uPAR)-a glycosyl-phosphatidyl-inositol-anchored membrane protein, interacting with urokinase. uPAR is able to form complexes with various transmembrane proteins such as integrins, activating intracellular signaling pathway and thus regulating multiple cell functions. We focused on studying the CD117+ population of cardiac mesenchymal progenitor cells (MPCs), expressing uPAR on their surface. It was found that the number of CD117+ MPCs in the heart of the uPAR-/- mice is lower, as well as their ability to proliferate in vitro compared with cells from wild-type animals. Knockdown of uPAR in CD117+ MPCs of wild-type animals was accompanied by a decrease in survival rate and Akt signaling pathway activity and by an increase in the level of caspase activity in these cells. That suggests the role of uPAR in supporting cell survival. After intramyocardial transplantation of uPAR(-) MPCs, reduced cell retention and angiogenesis stimulation were observed in mice with myocardial infarction model compared to uPAR(+) cells transplantation. Taken together, the present results appear to prove a novel mechanism of uPAR action in maintaining the survival and angiogenic properties of CD117+ MPCs. These results emphasize the importance of the uPAR as a potential pharmacological target for the regulation of reparative properties of myocardial mesenchymal progenitor cells.
No takes yet. Share an insight, caveat, or question.
Дергилев et al. (2023) studied Myocardial Infarction (preclinical model). uPAR(-) CD117+ mesenchymal progenitor cells vs. uPAR(+) CD117+ mesenchymal progenitor cells was evaluated on Cell retention and angiogenesis post-myocardial infarction. Transplantation of uPAR-deficient cardiac mesenchymal progenitor cells after myocardial infarction resulted in reduced cell retention and impaired angiogenesis compared to wild-type cells.
Synapse has enriched 10 related papers. Consider them for comparative context: